Lung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Stahl, Mirjam ^a   Schupp, Jonas ^a   Jag̈er, Benedikt ^a   Schmid, Michael ^a   Zissel, Gernot ^a   Mul̈ler Quernheim, Joachim ^a   Prasse, Antje ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; MSR1 PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SCAVENGER RECEPTOR A;

CASE CONTROL STUDY; CHEMISTRY; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; LUNG; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; MACROPHAGE; MACROPHAGE ACTIVATION; METABOLISM; PATHOLOGY; PHOSPHORYLATION;

CASE-CONTROL STUDIES; CHEMOKINE CCL2; COLLAGEN; COLLAGEN TYPE I; GENE EXPRESSION; HUMANS; LUNG; MACROPHAGE ACTIVATION; MACROPHAGES; MACROPHAGES, ALVEOLAR; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PULMONARY FIBROSIS; SCAVENGER RECEPTORS, CLASS A;

EID: 84894259338     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081382     Document Type: Article

References (34)

1. Gross TJ, Hunninghake GW (2001) Idiopathic pulmonary fibrosis. N Engl J Med 345: 517-525. doi:10.1056/NEJMra003200. PubMed: 11519507. (Pubitemid 32758505)
2. King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM (2001) Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 164: 1171-1181. doi:10.1164/ajrccm. 164.7.2003140. PubMed: 11673205. (Pubitemid 33052246)
3. Martinez FJ, Safrin S, Weycker D, Starko KM, Bradford WZ et al. (2005) The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 142: 963-967. doi:10.7326/0003-4819-142-12-Part-1-200506210-00005. PubMed: 15968010.
4. Laurent GJ (1986) Lung collagen: more than scaffolding. Thorax 41: 418-428. doi:10.1136/thx.41.6.418. PubMed: 3024347.
5. Hayashi T, Stetler-Stevenson WG, Fleming MV, Fishback N, Koss MN et al. (1996) Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am J Pathol 149: 1241-1256. PubMed: 8863673. (Pubitemid 26337243)
6. Dancer RC, Wood AM, Thickett DR (2011) Metalloproteinases in idiopathic pulmonary fibrosis. Eur Respir J 38: 1461-1467. doi:10.1183/09031936.00024711. PubMed: 21700608.
7. McKeown S, Richter AG, O'Kane C, McAuley DF, Thickett DR (2009) MMP expression and abnormal lung permeability are important determinants of outcome in IPF. Eur Respir J 33: 77-84. doi:10.1183/09031936.00060708. PubMed: 18829682.
8. Sweeney SM, Orgel JP, Fertala A, McAuliffe JD, Turner KR et al. (2008) Candidate cell and matrix interaction domains on the collagen fibril, the predominant protein of vertebrates. J Biol Chem 283: 21187-21197. doi:10.1074/jbc.M709319200. PubMed: 18487200.
9. Murray LA, Chen Q, Kramer MS, Hesson DP, Argentieri RL et al. (2011) TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P. Int J Biochem Cell Biol 43: 154-162. doi:10.1016/j.biocel.2010.10. 013. PubMed: 21044893.
10. Murray LA, Rosada R, Moreira AP, Joshi A, Kramer MS et al. (2010) Serum amyloid P therapeutically attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophages. PLOS ONE 5: e9683. doi:10.1371/journal.pone. 0009683. PubMed: 20300636.
11. Gibbons MA, MacKinnon AC, Ramachandran P, Dhaliwal K, Duffin R et al. (2011) Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. Am J Respir Crit Care Med 184: 569-581. doi:10.1164/rccm.201010-1719OC. PubMed: 21680953.
12. Pardo A, Smith KM, Abrams J, Coffman R, Bustos M et al. (2001) CCL18/DC-CK-1/PARC up-regulation in hypersensitivity pneumonitis. J Leukoc Biol 70: 610-616. PubMed: 11590198. (Pubitemid 32954772)
13. Prasse A, Pechkovsky DV, Toews GB, Jungraithmayr W, Kollert F et al. (2006) A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am J Respir Crit Care Med 173: 781-792. doi:10.1164/rccm.200509-1518OC. PubMed: 16415274.
14. Prasse A, Pechkovsky DV, Toews GB, Schäfer M, Eggeling S et al. (2007) CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis. Arthritis Rheum 56: 1685-1693. doi:10.1002/art.22559. PubMed: 17469163. (Pubitemid 46764100)
15. Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969. doi:10.1038/nri2448. PubMed: 19029990.
16. Mora AL, Torres-González E, Rojas M, Corredor C, Ritzenthaler J et al. (2006) Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis. Am J Respir Cell Mol Biol 35: 466-473. doi:10.1165/rcmb.2006-0121OC. PubMed: 16709958. (Pubitemid 44477646)
17. Gowen BB, Borg TK, Ghaffar A, Mayer EP (2001) The collagenous domain of class A scavenger receptors is involved in macrophage adhesion to collagens. J Leukoc Biol 69: 575-582. PubMed: 11310843. (Pubitemid 32294842)
18. Plüddemann A, Neyen C, Gordon S (2007) Macrophage scavenger receptors and host-derived ligands. Methods 43: 207-217. doi:10.1016/j.ymeth. 2007.06.004. PubMed: 17920517. (Pubitemid 47499075)
19. de Winther MP, van Dijk KW, Havekes LM, Hofker MH (2000) Macrophage scavenger receptor class A: A multifunctional receptor in atherosclerosis. Arterioscler Thromb Vasc Biol 20: 290-297. doi:10.1161/01.ATV.20.2.290. PubMed: 10669623. (Pubitemid 30086083)
20. Yu H, Ha T, Liu L, Wang X, Gao M et al. (2012) Scavenger receptor A (SR-A) is required for LPS-induced TLR4 mediated NF-kappaB activation in macrophages. Biochim Biophys Acta 1823: 1192-1198. doi:10.1016/j.bbamcr.2012.05. 004. PubMed: 22627090.
21. Yu X, Yi H, Guo C, Zuo D, Wang Y et al. (2011) Pattern recognition scavenger receptor CD204 attenuates Toll-like receptor 4-induced NF-kappaB activation by directly inhibiting ubiquitination of tumor necrosis factor (TNF) receptor-associated factor 6. J Biol Chem 286: 18795-18806. doi:10.1074/jbc. M111.224345. PubMed: 21460221.
22. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J et al. (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183: 788-824. doi:10.1164/rccm.2009-040GL. PubMed: 21471066.
23. Gardi C, Pacini A, de Santi MM, Calzoni P, Viti A et al. (1990) Development of interstitial lung fibrosis by long-term treatment with collagen breakdown products in rabbits. Res Commun Chem Pathol Pharmacol 68: 235-250. PubMed: 2353133. (Pubitemid 20178451)
24. Yano S, Yanagawa H, Nishioka Y, Mukaida N, Matsushima K et al. (1996) T helper 2 cytokines differently regulate monocyte chemoattractant protein-1 production by human peripheral blood monocytes and alveolar macrophages. J Immunol 157: 2660-2665. PubMed: 8805671. (Pubitemid 126450483)
25. Pechkovsky DV, Prasse A, Kollert F, Engel KM, Dentler J et al. (2010) Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction. Clin Immunol 137: 89-101. doi:10.1016/j.clim.2010.06.017. PubMed: 20674506.
26. Gowen BB, Borg TK, Ghaffar A, Mayer EP (2000) Selective adhesion of macrophages to denatured forms of type I collagen is mediated by scavenger receptors. Matrix Biol 19: 61-71. doi:10.1016/S0945-053X(99)00052-9. PubMed: 10686426.
27. Cholewa J, Nikolic D, Post SR (2010) Regulation of class A scavenger receptor-mediated cell adhesion and surface localization by PI3K: identification of a regulatory cytoplasmic motif. J Leukoc Biol 87(3): 443-9.28.
28. Higashi-Kuwata N, Jinnin M, Makino T, Fukushima S, Inoue Y et al. (2010) Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis. Arthritis Res Ther 12: R128. doi:10.1186/ar3066. PubMed: 20602758.
29. Liu CY, Xu JY, Shi XY, Huang W, Ruan TY, et al. (2013) M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway. Lab Invest 93(7): 844-854. doi:10.1038/labinvest.2013.69. PubMed: 23752129.
30. Shiraishi D, Fujiwara Y, Komohara Y, Mizuta H, Takeya M (2012) Glucagon-like peptide-1 (GLP-1) induces M2 polarization of human macrophages via STAT3 activation. Biochem Biophys Res Commun 425: 304-8.31. PubMed: 22842565.
31. Hsu HY, Chiu SL, Wen MH, Chen KY, Hua KF (2001) Ligands of macrophage scavenger receptor induce cytokine expression via differential modulation of protein kinase signaling pathways. J Biol Chem 276: 28719-28730. doi:10.1074/jbc.M011117200. PubMed: 11390374.
32. Beamer CA, Holian A (2005) Scavenger receptor class A type I/II (CD204) null mice fail to develop fibrosis following silica exposure. Am J Physiol Lung Cell Mol Physiol 289: L186-L195. doi:10.1152/ajplung.00474.2004. PubMed: 15849212. (Pubitemid 41008900)
33. Rauh MJ, Ho V, Pereira C, Sham A, Sly LM et al. (2005) SHIP represses the generation of alternatively activated macrophages. Immunity 23: 361-374. doi:10.1016/j.immuni.2005.09.003. PubMed: 16226502. (Pubitemid 41443438)
34. Nikolic DM, Cholewa J, Gass C, Gong MC, Post SR (2007) Class A scavenger receptor-mediated cell adhesion requires the sequential activation of Lyn and PI3-kinase. Am J Physiol Cell Physiol 292: C1450-C1458. PubMed: 17192284. (Pubitemid 46631728)